Celularity Common Stock Total Equity Over Time
| CELU Stock | USD 3.05 0.26 7.85% |
With this module, investors can use any or all of fundamental ratio historical patterns as a complementary method for asset selection as well as a tool for deciding entry and exit points. Many technical investors use fundamentals to limit their universe of possible portfolio assets.
Check out Celularity Performance and Celularity Correlation. Celularity |
Is Celularity's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Celularity. If investors know Celularity will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Celularity listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth (0.93) | Earnings Share (10.30) | Revenue Per Share 0.887 | Quarterly Revenue Growth (0.08) | Return On Assets (0.20) |
The market value of Celularity is measured differently than its book value, which is the value of Celularity that is recorded on the company's balance sheet. Investors also form their own opinion of Celularity's value that differs from its market value or its book value, called intrinsic value, which is Celularity's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Celularity's market value can be influenced by many factors that don't directly affect Celularity's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Celularity's value and its price as these two are different measures arrived at by different means. Investors typically determine if Celularity is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Celularity's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Cross Equities Common Stock Total Equity Analysis
Compare Celularity and related stocks such as Immix Biopharma, ZyVersa Therapeutics, and Hepion Pharmaceuticals Common Stock Total Equity Over Time
Select Fundamental| 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| HEPA | 900 | 900 | 900 | 1.8 K | 1.8 K | 2.2 K | 3.2 K | 7.6 K | 1.7 K | 375 | 3.2 K | 7.6 K | 7.6 K | 8.8 K | 9.2 K |
| AVRO | 2 K | 2 K | 2 K | 2 K | 2 K | 2 K | 2 K | 2 K | 2 K | 3 K | 4 K | 4 K | 4 K | 4.6 K | 3.6 K |
| EFTR | 454 | 454 | 454 | 454 | 454 | 454 | 454 | 454 | 454 | 454 | 454 | 4 K | 4 K | 4.6 K | 2.4 K |
| CNSP | 10.3 K | 10.3 K | 10.3 K | 10.3 K | 10.3 K | 10.3 K | 10.3 K | 10.3 K | 12.7 K | 16.4 K | 23.9 K | 23.9 K | 23.9 K | 27.4 K | 17.4 K |
| SONN | 301 | 301 | 301 | 541 | 725 | 2.1 K | 2.1 K | 310 | 370 | 555 | 1.5 K | 1.5 K | 1.5 K | 1.7 K | 973 |
Celularity and related stocks such as Immix Biopharma, ZyVersa Therapeutics, and Hepion Pharmaceuticals Common Stock Total Equity description
The total value of common stock equity held by shareholders, representing their ownership interest in the company.My Equities
My Current Equities and Potential Positions
| Celularity | CELU |
Specialization | Health Care, Pharmaceuticals, Biotechnology & Life Sciences |
| Location | New York; U.S.A |
| Exchange | NASDAQ Exchange |
USD 3.05
Check out Celularity Performance and Celularity Correlation. For more information on how to buy Celularity Stock please use our How to Invest in Celularity guide.You can also try the Alpha Finder module to use alpha and beta coefficients to find investment opportunities after accounting for the risk.
Complementary Tools for Celularity Stock analysis
When running Celularity's price analysis, check to measure Celularity's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Celularity is operating at the current time. Most of Celularity's value examination focuses on studying past and present price action to predict the probability of Celularity's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Celularity's price. Additionally, you may evaluate how the addition of Celularity to your portfolios can decrease your overall portfolio volatility.
| Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
| Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
| Global Correlations Find global opportunities by holding instruments from different markets | |
| Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas | |
| Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
| Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes | |
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
| Volatility Analysis Get historical volatility and risk analysis based on latest market data |
Celularity technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.